Vyaire Medical

Vyaire Medical

Vyaire Medical was formed in 2016 as a carve-out from Becton Dickinson's respiratory solutions business, with private equity backing from Apax Partners and a consortium of investors. The company operates as a standalone manufacturer of respiratory diagnostics and therapeutic devices. The company's product portfolio includes ventilators, pulse oximeters, spirometers, anesthesia machines, and neonatal intensive care equipment. Vyaire sells to hospitals, clinic networks, and home healthcare providers across North America, Europe, and Asia. The company has not publicly disclosed specific investment returns or AUM figures. Vyaire Medical reported revenue of approximately $1.2 billion in 2022 (per industry reports). The company employed roughly 5,000 professionals globally as of its separation. No additional offices beyond its US headquarters have been publicly listed. As a private equity-backed carve-out, Vyaire operates with a capital structure typical of leveraged buyouts: debt-financed with operational improvement targets. Its distinct position comes from being a pure-play respiratory device manufacturer in a market dominated by diversified conglomerates.